Walvax Biotechnology Co., Ltd. 300142.SZ Stock
Walvax Biotechnology Co., Ltd. Price Chart
Walvax Biotechnology Co., Ltd. 300142.SZ Financial and Trading Overview
Walvax Biotechnology Co., Ltd. stock price | 14.35 CNY |
Previous Close | 27.02 CNY |
Open | 26.9 CNY |
Bid | 26.95 CNY x 0 |
Ask | 26.96 CNY x 0 |
Day's Range | 26.76 - 27.18 CNY |
52 Week Range | 26.19 - 51.32 CNY |
Volume | 13.82M CNY |
Avg. Volume | 14.25M CNY |
Market Cap | 43.37B CNY |
Beta (5Y Monthly) | 0.757534 |
PE Ratio (TTM) | 49.054543 |
EPS (TTM) | 0.26 CNY |
Forward Dividend & Yield | 0.01 (0.040%) |
Ex-Dividend Date | May 11, 2023 |
1y Target Est | 36 CNY |
300142.SZ Valuation Measures
Enterprise Value | 41.88B CNY |
Trailing P/E | 49.054543 |
Forward P/E | 24.752293 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 8.238557 |
Price/Book (mrq) | 4.6662054 |
Enterprise Value/Revenue | 7.957 |
Enterprise Value/EBITDA | 29.049 |
Trading Information
Walvax Biotechnology Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.757534 |
52-Week Change | -42.86% |
S&P500 52-Week Change | 20.43% |
52 Week High | 51.32 CNY |
52 Week Low | 26.19 CNY |
50-Day Moving Average | 30.95 CNY |
200-Day Moving Average | 37.68 CNY |
300142.SZ Share Statistics
Avg. Volume (3 month) | 14.25M CNY |
Avg. Daily Volume (10-Days) | 15.69M CNY |
Shares Outstanding | 1.61B |
Float | 1.36B |
Short Ratio | N/A |
% Held by Insiders | 16.45% |
% Held by Institutions | 10.88% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.01 |
Trailing Annual Dividend Yield | 0.037% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0502 |
Last Split Factor | 30:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 16.37% |
Operating Margin (ttm) | 22.13% |
Gross Margin | 86.32% |
EBITDA Margin | 27.39% |
Management Effectiveness
Return on Assets (ttm) | 4.94% |
Return on Equity (ttm) | 9.93% |
Income Statement
Revenue (ttm) | 5.26B CNY |
Revenue Per Share (ttm) | 3.29 CNY |
Quarterly Revenue Growth (yoy) | 27.00% |
Gross Profit (ttm) | 4.48B CNY |
EBITDA | 1.44B CNY |
Net Income Avi to Common (ttm) | 862.02M CNY |
Diluted EPS (ttm) | 0.55 |
Quarterly Earnings Growth (yoy) | 345.30% |
Balance Sheet
Total Cash (mrq) | 3.82B CNY |
Total Cash Per Share (mrq) | 2.38 CNY |
Total Debt (mrq) | 498.01M CNY |
Total Debt/Equity (mrq) | 4.45 CNY |
Current Ratio (mrq) | 2.66 |
Book Value Per Share (mrq) | 5.782 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.39B CNY |
Levered Free Cash Flow (ttm) | -568080960 CNY |
Profile of Walvax Biotechnology Co., Ltd.
Country | China |
State | N/A |
City | Kunming |
Address | Building 9A, 19th Floor |
ZIP | 650106 |
Phone | 86 871 6333 0984 |
Website | https://www.walvax.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2249 |
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
Q&A For Walvax Biotechnology Co., Ltd. Stock
What is a current 300142.SZ stock price?
Walvax Biotechnology Co., Ltd. 300142.SZ stock price today per share is 14.35 CNY.
How to purchase Walvax Biotechnology Co., Ltd. stock?
You can buy 300142.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Walvax Biotechnology Co., Ltd.?
The stock symbol or ticker of Walvax Biotechnology Co., Ltd. is 300142.SZ.
Which industry does the Walvax Biotechnology Co., Ltd. company belong to?
The Walvax Biotechnology Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Walvax Biotechnology Co., Ltd. have in circulation?
The max supply of Walvax Biotechnology Co., Ltd. shares is 1.61B.
What is Walvax Biotechnology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Walvax Biotechnology Co., Ltd. PE Ratio is 55.19231000 now.
What was Walvax Biotechnology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Walvax Biotechnology Co., Ltd. EPS is 0.26 CNY over the trailing 12 months.
Which sector does the Walvax Biotechnology Co., Ltd. company belong to?
The Walvax Biotechnology Co., Ltd. sector is Healthcare.
Stocks Related By Sector
- Shenzhen Kangtai Biological Products Co., Ltd. 300601.SZ Stock
- Zhejiang Huahai Pharmaceutical Co., Ltd. 600521.SS Stock
- Guangzhou Kingmed Diagnostics Group Co., Ltd. 603882.SS Stock
- Joincare Pharmaceutical Group Industry Co.,Ltd. 600380.SS Stock
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 600329.SS Stock
Stocks Related By Industry
- Shenzhen Kangtai Biological Products Co., Ltd. 300601.SZ Stock
- Zhejiang Huahai Pharmaceutical Co., Ltd. 600521.SS Stock
- Joincare Pharmaceutical Group Industry Co.,Ltd. 600380.SS Stock
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 600329.SS Stock
- China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS Stock